Studies found that Sirt3 increases the anti-oxidant capacity of cells by deacetylating mitochondrial proteins including SOD2 in age-related diseases such as neurodegenerative diseases and cardiovascular diseases (44, 45). This evidence concerns the gene SOD2 and neurodegenerative disease.